|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prediagnostic Leptin, Adiponectin, C-reactive Protein, and the Risk of Postmenopausal Breast Cancer 显示文摘 | Ollberding N J Kim Y Shvetsov Y B | 2013 | Cancer Prevention Research2013，6，3： | 1 |
| 2 | Prediagnostic leptin, adiponectin,C-reactive protein,and the risk of postmenopausal breast cancer显示文摘 | Ollberding NJ Kim Y Shvetsov YB | 2013 | Cancer Prev Res (Phila)2013，6，3： | 1 |
| 3 | Prediagnostic lep tin,adiponectin,C reactive protein,and the risk of postmeno- pausal breast cancer显示文摘 | Ollberding NJ Kim Y Shvetsov YB | 2013 | Cancer Prev Res(Phila)2013，6，3： | 1 |
| 4 | Prediagnostic leptin,adiponectin, C ,reactive protein and the risk of postrnenopausal breast cancer 显示文摘 | Ollberding N J Kim Y Shvetsov YB | 2013 | Cancer Prev Res (Phi- la)2013，6，3： | 1 |
| 5 | Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries显示文摘AIM To compare patients who underwent resection of early stage hepatocellular cancer(HCC) in three different countries. METHODS This retrospective study characterizes 573 stage Ⅰ/Ⅱ HCC patients treated with liver resection in 3 tertiaryreferral centers: Tokyo(n = 250), Honolulu(n = 146) and Shanghai(n = 177).RESULTS Shanghai patients were younger, predominantly male, hepatitis-B seropositive(94%) and cirrhotic(93%). Tokyo patients were older and more likely to have hepatitis-C(67%), smaller tumors, low albumin, and normal alpha-fetoprotein. The Honolulu cohort had the largest tumors and 30% had no viral hepatitis. Ageadjusted mortality at 1 and 5-years were lower in theTokyo cohort compared to Honolulu and there was no difference in mortality between Shanghai and Honolulu cohorts. Elevated alpha-fetoprotein, low albumin and tumor > 5 cm were associated with increased 1-year mortality. These factors and cirrhosis were independently associated with increased 5-year mortality. Independent risk factors of survival varied when examined separately by center. CONCLUSION The profile of early-stage HCC patients is strikingly different across countries and likely contributes to survival differences. Underlying differences in patient populations including risk factors/comorbidities influencing disease progression may also account for variation in outcomes. | Linda L Wong Brenda Y Hernandez Yurii B Shvetsov Yoichi Kawano Zhao-You Tang Jun-Fang Ji | 2016 | World Journal of Hepatology2016，8，31： | 1 |
| 6 | Settlement Formation Modelswith Entropy Operator显示文摘 | Popkov Y S Shvetsov V I Weidlieh W | 1998 | The Annals of Regional Science1998，32，2： | 1 |
| 7 | Plasma sex hor- mone concentrations and breast cancer risk in an ethnically di- verse population of postmenopausal women; the Multiethnic Cohort Study 显示文摘 | Woolcott C Shvetsov Y Stanczyk F | 2010 | Endocr Relat Cancer2010，17，1： | 1 |
| 8 | Prevalence, acquisition, and clearance of cervical human papiIlomavirus infection a- mong women with normal cytology : Hawaii Human Papillomavirus Co- hart Study显示文摘 | GOODMAN M T SHVETSOV Y B MCDUFFIE K | 2008 | Cancer Res2008，68，21： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员